Table 2.
Patient medication
Measurement | Patient group |
||
---|---|---|---|
Exacerbated COPD | Stable COPD | Non-obstructed smokers | |
No. patients | 136 | 68 | 16 |
Short acting β2 agonist | 80 | 40 | 0 |
Long acting β2 agonist | 57 | 42 | 0 |
Inhaled steroid | 94 | 53 | 0 |
Inhaled steroid (BDP) | 1040 ± 727 | 949 ± 588 | – |
Oral theophylline | 45 | 23 | 0 |
Theophylline (mg) | 482 ± 189 | 524 ± 198 | – |
Nebulised therapy | 86 | 28 | 0 |
Home oxygen | 39 | 11 | 0 |
Maintenance oral steroids | 9 | 6 | 0 |